Month: March 2026

Findings underpin potential of Anavex’ lead candidate blarcamesine through its upstream mechanism of action and SIGMAR1-mediated autophagy restoration NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that a new peer-reviewed study published by University of California in Proceedings of the National Academy of Sciences, Nexus1 (Shoff et al., 2026) supports the hypothesis that disruption of neuronal homeostasis—particularly autophagy impairment—acts upstream of amyloid...

Vancouver, BC, March 20, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X45) (“Deep Sea Minerals” or the “Company”), a subsea mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, is pleased to announce that it has submitted its bid in response to a solicitation from the U.S. Defense Industrial Base Consortium (the “DIBC”) to provide to the United States a reliable supply of critical minerals, focusing on Nickel (Ni), and a complementary commercialization plant. In February 2026, the DIBC issued a new request for project proposal (“RPP”) focused on strategic critical minerals. The DoW has prioritized identification of supply chain alternatives for defense-critical minerals used in the production of aircraft, missiles,...

HOUSTON and LONDON, March 20, 2026 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR) will announce the results of the first quarter ending March 31, 2026, via press release at 5 p.m. Eastern Time (4 p.m. Central Time) on Thursday, April 23, 2026. A webcast to discuss the results will be held Friday, April 24, at 9:30 a.m. Eastern Time (8:30 a.m. Central Time). To access the webcast, listeners should visit the Baker Hughes website at: investors.bakerhughes.com. An archived version will be available on the website following the webcast. About Baker HughesBaker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120 countries, our innovative technologies and services are taking energy forward – making...

Specialty Connector Order Under 10-Year Agreement Reinforces OMS Saudi’s Position as a Premier Regional Supplier Singapore, March 20, 2026 (GLOBE NEWSWIRE) — OMS Energy Technologies Inc. (“OMS” or the “Company”) (NASDAQ: OMSE), a growth-oriented manufacturer of surface wellhead systems (“SWS”) and oil country tubular goods (“OCTG”) for the oil and gas industry, today announced that its wholly-owned subsidiary, OMS Oilfield Services Arabia Ltd. (“OMS Saudi”), has received a US$11 million call-off order for specialty connectors and pipes under the Company’s existing long-term supply agreement with Saudi Aramco, the world’s largest oil producer. The products are expected to be delivered during calendar year 2026. The Company’s supply agreement with Saudi Aramco, signed in early 2024, operates on a call-off...

Thomas A. Zalewski, a Partner at Day Pitney LLP, appointed Chief Legal Officer and Chief Compliance Officer effective April 2, 2026 Lori J. Braender to remain in a non-executive role as Corporate Secretary after nearly eight years as Chief Legal Officer, Chief Compliance Officer and Corporate SecretaryWARREN, N.J., March 20, 2026 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced the appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer, effective April 2, 2026, succeeding Lori J. Braender, who will be stepping down as Chief Legal Officer and Chief Compliance...

212,156 Performance Incentive Grants were exercised at $9.64 per share between January 30, 2026, and March 17, 2026, generating $2,045,184 in proceeds for WeShop Proceeds will support working capital and general corporate purposes as WeShop continues expansion across North AmericaLONDON, March 20, 2026 (GLOBE NEWSWIRE) — WeShop Holdings Limited (“WeShop” or the “Company”) (NASDAQ: WSHP), the world’s first community-owned social commerce platform, today announced that holders of the WeShop Performance Incentive Grants have exercised their grants to purchase the Company’s Class A ordinary shares.  Since the listing on 14th November 2025, the holders of Performance Incentive Grants have exercised a total of 212,156 grants at $9.64 per share.  These exercises generated aggregate proceeds to the Company of $2,045,184. The proceeds...

EL MONTE, Calif., March 20, 2026 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced a marketplace initiative with Otto Group, one of Europe’s largest ecommerce and retail enterprises. As part of this initiative, GigaCloud will facilitate the introduction of select sellers, including leading furniture brands and suppliers, to Otto’s established European selling platform. The initiative is intended to broaden marketplace assortment while leveraging GigaCloud’s global supplier network and technology capabilities. “This collaboration aligns with our channel-agnostic strategy and reinforces our role as a marketplace solutions provider, connecting global supply with established selling...

VANCOUVER, British Columbia, March 20, 2026 (GLOBE NEWSWIRE) — Canterra Minerals Corporation (TSXV:CTM) (OTCQB: CTMCF) (FSE:DXZB) (“Canterra” or the “Company”) is pleased to announce it has engaged Atrium Research Corporation (“Atrium”), a prominent firm specializing in company-sponsored research, to support broader market awareness of Canterra’s exploration portfolio and ongoing 2026 drill programs. Atrium will be responsible for publishing various research reports on Canterra. These reports will be based on publicly available information, industry data, and direct discussions with the Company’s management and are expected to provide investors with detailed, third-party analysis of Canterra’s assets and exploration strategy. Additionally, Atrium will conduct and host two recorded interviews with Canterra’s...

SAN DIEGO, March 20, 2026 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will host a key opinion leader (KOL) webinar to discuss the emergent treatment landscape in first-line RAS-mutated metastatic colorectal cancer (mCRC). The webinar will take place on Wednesday, March 25th, 2026, at 4:30 p.m. ET. The webinar will feature KOLs Scott Kopetz, M.D., Ph.D., FACP and Heinz-Josef Lenz, M.D., who will join Mani Mohindru, PhD, interim Chief Executive Officer, to discuss onvansertib’s existing clinical data and its potential as a novel therapeutic approach in the management of mCRC. About the KOLs Scott Kopetz, M.D., Ph.D., FACP, is a Professor in the Department of Gastrointestinal...